ABCANN GLOBAL CORPORATION (CVE:ABCN) reported that its common shares have been listed on the OTCQB Marketplace under the ticker “ABCCF” and on the Frankfurt Stock Exchange under the ticker “23Q”. The firm’s common shares will continue to list on the TSX Venture Exchange under the ticker “ABCN”.
ABcann reported that it can benefit from the latest move of being listed on the FSE and the OTCQB by getting increased visibility and convenience of trading the firm’s common shares to European and U.S. shareholders, permitting a much larger prospective shareholder base and improved liquidity.
As it is known, the company comes in the list of early pioneers to avail a manufacturing approval under the Marijuana for Medical Purposes Regulations. It was awarded with the manufacturing license back on March 21, 2014 and procured a sales license on December 31, 2015.
ABcann’s leading facility, in Napanee, constitutes proprietary crop-growing know-how, comprising environmentally-controlled chambers capable of regulating and checking all variables in the growing course. This systems and approach allows the company to produce naturally grown and pesticide-free, high-yielding crops, which eventually can generate best products that are constant from batch to batch.
ABcann has capability to control nutrient and ecofriendly demands, tailor-made for a certain strain of cannabis, and that too without the variation that is common when doing mass production in less controlled, spacious rooms and greenhouse-type structures.
It has modular process to systems technology which removes scale-up risk and enhances quality and consistency of product. For now, the company is in the process of expanding its capacity in its existing facility.
In the last trading session, the stock price of ABcann declined more than 1% to close the week at CAD$0.880. After the recent drop, the market cap of firm stands around CAD$50 million. The 52-week range of stock is 0.01 – 1.50.